FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 1 | 0 |
% | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Avoid |
[Dilip Davda] After showing dismal performances for FY20 and FY21, it marked a bumper turnover and net profits, which appears to be a window dressing in a pre-IPO year. DPL is just a trader in pharmachem. Since it is operating in a highly competitive and fragmented segment, the sustainability of such performance is a major concern. Based on such super profits also the issue is aggressively priced. There is no harm in ignoring such a pricy bet. Read detail review...
Dipna Pharmachem IPO Reviews, analysis and views by popular members. Read Dipna Pharmachem Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 3 | 0 | 0 | 1 |
% | 75.00 | 0.00 | 0.00 | 25.00 |
Member | Review |
---|---|
Raghavendra C S |
Avoid Please don't lose your money, please follow Devda sir. if applied u can still cancel IPO. August 29, 2022 12:44:54 PM |
RajaBanks |
Apply for Short Term at Cut-off Price Hi to whoever came here to check if this IPO is risky or not- All IPOs are risky. |
SahaniAlok |
Apply for Listing Gain at Cut-off Price I think this IPO will open with listing gain August 25, 2022 3:24:11 PM |
Tenscope Management |
Apply for Listing Gain at Upper Price Band Listing gain chances full August 29, 2022 2:24:30 AM |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|